Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer.

Xu, Chaojie; Pei, Dongchen; Liu, Yi; Guo, Jianhua; Liu, Nan; Wang, Qian; Yu, Yang; Kang, Zhengjun

Xu, Chaojie; Pei, Dongchen; Liu, Yi; Guo, Jianhua; Liu, Nan; Wang, Qian; Yu, Yang; Kang, Zhengjun.

Afiliação

Xu C; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Pei D; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Liu Y; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Guo J; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Liu N; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Wang Q; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yu Y; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Kang Z; Department of Urology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.

Front Oncol ; 13: 918324, 2023.

Article em En | MEDLINE | ID: mdl-37260974

Palavras-chave

SEER database; competing risk regression analysis; nomogram; prostate cancer-specific mortality (PSCM); second primary malignancy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google